sj-docx-1-tan-10.1177_17562864221149781 – Supplemental material for Evaluation of rAAVrh74 gene therapy vector seroprevalence by measurement of total binding antibodies in patients with Duchenne muscular dystrophy

Goedeker, Natalie L.; Dharia, Sachi D.; Griffin, Danielle A.; Coy, Jesantha; Truesdale, Todd; Parikh, Rajan; Whitehouse, Kasen; Santra, Sourav; Asher, Damon R.; Zaidman, Craig M.

doi:10.25384/SAGE.21951406.v1

sj-docx-1-tan-10.1177_17562864221149781.docx (43.75 kB)

sj-docx-1-tan-10.1177_17562864221149781 – Supplemental material for Evaluation of rAAVrh74 gene therapy vector seroprevalence by measurement of total binding antibodies in patients with Duchenne muscular dystrophy

journal contribution

posted on 2023-01-25, 03:30 authored by Natalie L. Goedeker, Sachi D. Dharia, Danielle A. Griffin, Jesantha Coy, Todd Truesdale, Rajan Parikh, Kasen Whitehouse, Sourav Santra, Damon R. Asher, Craig M. Zaidman

Supplemental material, sj-docx-1-tan-10.1177_17562864221149781 for Evaluation of rAAVrh74 gene therapy vector seroprevalence by measurement of total binding antibodies in patients with Duchenne muscular dystrophy by Natalie L. Goedeker, Sachi D. Dharia, Danielle A. Griffin, Jesantha Coy, Todd Truesdale, Rajan Parikh, Kasen Whitehouse, Sourav Santra, Damon R. Asher and Craig M. Zaidman in Therapeutic Advances in Neurological Disorders